Alessandra Ferro

5PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersModelling and simulationSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 09, 2025
Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors.

Francesca Lunardi, Alessandra Ferro, Luca Vedovelli

|Aug 14, 2025
RadiomiX for Radiomics Analysis: Automated Approaches to Overcome Challenges in Replicability.

Harel Kotler, Luca Bergamin, Fabio Aiolli

|Mar 23, 2024
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.

Giulia Pasello, Martina Lorenzi, Daniela Scattolin

|Aug 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.

Laura Bonanno, Martina Lorenzi, Davide Massa

|Nov 26, 2022
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.

Alessandra Ferro, Matteo Sepulcri, Marco Schiavon

Pageof 1

Frequent Collaborators

3 joint publications

Alessandro Dal Maso

3 joint publications

Giulia Pasello

2 joint publications

Francesca Lunardi

2 joint publications

Laura Bonanno